Prim S.A. Logo

Prim S.A.

PRM | MC

Overview

Corporate Details

ISIN(s):
ES0170884417
LEI:
959800M75M81U0Y2UX24
Country:
Spain
Address:
AVDA. LLANO CASTELLANO 43, 28034 Móstoles
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Prim S.A. is a healthcare technology company with over 150 years of history. The company designs, manufactures, commercializes, and installs products and equipment that provide advanced solutions for the healthcare system. Its core offerings include hospital and orthopedic supplies, pharmaceutical products, and equipment for physiotherapy, rehabilitation, thalassotherapy, and spa facilities. Prim focuses on delivering innovative technology to improve mobility, independence, and overall quality of life for individuals, positioning itself as a strategic partner within the health sector.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Prim S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-09 00:00
Post-Annual General Meeting Information
Comunicación acuerdos de ampliación del Consejo y de Nombramiento y Reelección …
Spanish 155.2 KB
2025-07-02 00:00
Post-Annual General Meeting Information
Se adjuntan resultados de la votación de las propuestas de acuerdo de la Junta …
English 16.1 KB
2025-05-29 11:01
Investor Presentation
Avance plan estratégico, resumen ejecutivo 2021-2024 y Avance ESG (hitos 2024 y…
Spanish 2.2 MB
2025-05-27 14:16
Pre-Annual General Meeting Information
Convocatoria Junta General Ordinaria de Accionistas de la Sociedad el 29 de jun…
Spanish 172.0 KB
2025-05-27 00:00
Pre-Annual General Meeting Information
Convocatoria Junta General Ordinaria de Accionistas de la Sociedad el 29 de jun…
Spanish 172.0 KB
2025-05-06 09:33
Related Party Transaction
Información de las operaciones realizadas desde el cierre del primer trimestre …
Spanish 334.4 KB
2025-04-29 09:24
Earnings Release
Presentación de resultados primer trimestre 2025
Spanish 421.0 KB
2025-04-01 11:23
Transaction in Own Shares
Operaciones realizadas al amparo del contrato de liquidez durante el primer tri…
Portuguese 324.2 KB
2025-03-31 16:59
Annual / Quarterly Financial Statement
La sociedad remite el Informe Financiero Anual del ejercicio 2024
Spanish 275.9 KB
2025-03-31 15:56
Interim Report
La sociedad remite información financiera del segundo semestre de 2024
Spanish 186.3 KB
2025-03-31 11:57
Environmental & Social Information
Estado de Información no financiera (EINF) Consolidado e Informe de Sostenibili…
Spanish 9.1 MB
2025-03-31 10:24
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 207.0 KB
2025-03-31 10:20
Major Shareholding Notification
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 420.4 KB
2025-03-31 00:00
Annual Report (ESEF)
Spanish 17.4 MB
2025-02-28 08:25
Notice of Dividend Amount
Comunicación pago segundo dividendo a cuenta del ejercicio 2024
Spanish 113.6 KB

Automate Your Workflow. Get a real-time feed of all Prim S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prim S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN